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Case Report

Craniopharyngioma causing bilateral vision loss
4 months after unremarkable magnetic resonance
imaging of the brain
Rainy Betts1, Curtis E. Margo1,2, Mitchell Drucker1
Departments of 1Ophthalmology and 2Pathology and Cell Biology, University of South Florida, Morsani College of Medicine, Tampa, FL, USA

ABSTRACT
A 65‑year‑old man developed bilateral vision loss 4 months after magnetic resonance imaging demonstrated no
lesion in the vicinity of the optic chiasm, hypothalamus, and suprasellar tissues. Repeat computed tomography
3 months later showed a predominantly cystic mass of the suprasellar cistern with extension into the anterior third
ventricle, which histologically was a craniopharyngioma. The clinical course of this case fuels the controversy whether
craniopharyngiomas arise from embryonic rests or can be acquired. From a clinical perspective, it raises questions
about when to obtain imaging studies dedicated to the chiasm and the appropriate interval in which a scan should
be repeated to exclude structural causes of bilateral vision loss.
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Introduction
The cellular origin of craniopharyngioma is controversial.
The bimodal age distribution that peaks in childhood and
in adults between the ages of 40 and 70 years supports
both the theory that tumors can arise from embryonic
rests of squamous cells or through an acquired
process of squamous metaplasia of cells normally
found in or near the adenohypothysis.[1] We describe a
65‑year‑old man who developed a clinically symptomatic
craniopharyngioma 4 months after magnetic resonance
imaging (MRI) had shown no anatomic abnormalities in
the region of Rathke’s pouch.

Case Report
A 65‑year‑old man with past history of diabetes mellitus,
carotid artery disease, coronary artery atherosclerotic
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heart disease, sleep apnea, and hypertension was
referred for evaluation of decreased vision of the left
eye for 4 weeks. Four months earlier, he had MRI and
magnetic resonance angiography for evaluation of
dizziness, which had shown no anatomic abnormalities
in the sellar region. Nor were any abnormalities of
the hypothalamus, suprasellar region, or anterior
third ventricle detected [Figure 1]. Dizziness resolved
spontaneously. On examination, visual acuity was
20/40 OD and 20/80 OS; there was no afferent pupillary
defect but color vision was decreased in both eyes, and
central scotomas were found with red color test objects
in both eyes. Relevant findings on ophthalmoscopy
were temporal pallor of both nerves. Satisfied that the
recent MRI showed no pathological lesion, no further
neuroradiological studies were obtained. Laboratory
evaluation revealed a normal complete blood count,
serum folate, and serum vitamin B12. Serological
test for syphilis and urine heavy metal screen were
negative. Three months later the patient developed a
new headache and vision had progressively worsened
to counting fingers OU. Computed tomography (CT)
showed a 2.5 cm predominantly cystic mass centered in
the suprasellar cistern with extension into anterior third
ventricle [Figure 2a and b]. Endoscopic subtotal resection
revealed a papillary craniopharyngioma [Figure 2c]. The
patient was referred to radiation therapy.
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Figure 1: (a) Sagittal T1-weighted magnetic resonance imaging (MRI)
in the midline showing normal sellar and suprasellar structures. There
is mild thickening of the pituitary stalk but no evidence of a mass (this
thickening was appreciated 7 months later in retrospect). (b) Fluid
attenuation inversion recovery image just rostral to the chiasm and
optic nerves showing no lesions in or around anterior third ventricle.
(c) A coronal T2-weighted MRI at the level of the basilar artery (arrow)
just posterior to the chiasm showing no evidence of a mass (a = left;
b = upper right; c = lower right)

Discussion
There are 2 previous reports of craniopharyngioma
arising in adults after normal neuro‑radiologic studies.
One occurred in a 39‑year‑old woman whose diagnosis
was made during pregnancy.[2] She had a normal MRI
4 years earlier. The other developed in a 55‑year‑old
man 2 years after a normal MRI. [3] These cases in
addition to ours suggest that some tumors may arise
de novo. Our patient sustained an injury to the visual
pathway within 4 months of an unremarkable imaging
study of the brain. Based on experience with the size
most craniopharyngiomas obtain to deform the chiasm
and become symptomatic, it was believed that the
initial study sufficiently excluded a mass lesion in the
suprasellar region.[4] This assumption may not have
been justified.
Craniopharyngiomas are described as slow growing
tumors.[5] A rare report of malignant transformation
has appeared in the literature, but the vast majority
of craniopharyngiomas show no significant
cytological pleomorphism. The perception that most
craniopharyngiomas undergo slow protracted growth
prior to primary clinical detection is supported by
observations of low mitotic activity and low Ki‑67
labeling indicies. [6,7] Tumors with reportedly rapid
growth or enlargement occur in the context of recurrent
lesions, some of which have been reported following
growth hormone replacement.[8,9] Long‑term growth
hormone replacement does not appear to be an important
risk factor for recurrence, however, compared to such

c

Figure 2: (a) Computed tomogram 7 months after magnetic resonance
imaging study shown in Figure 1. Sagittal reconstruction shows cystic
mass (arrows) in the suprasellar cistern. (b) Coronal reconstruction
at the level of the basilar artery (arrow) demonstrates cystic mass.
The lesion is slightly hyperdense to cerebral spinal fluid in the third
ventricle. (c) Microscopic examination of the partially removed tumor
demonstrated sheets of squamous epithelium with peripheral palisading
and intervening fibrovascular connective tissue. No mitotic figures were
seen (H and E, bar = 80 microns) (a = left; b = upper right; c = lower right)

factors as residual tumor and initial radiation therapy.[10]
More germane to this case, however, is the rate of growth
prior to surgical treatment. The early natural history
of craniopharyngiomas is essentially unknown since
therapeutic interventions usually follow the initial
discovery.
Several mechanisms may explain the presumably rapid
enlargement of the tumor in our patient. It is possible
that the enlarged pituitary stalk in the initial MRI (but
only appreciated in retrospect) harbored a small cystic
craniopharyngioma. Its enlargement could have
occurred due to spontaneous rupture of the cyst or from
secondary hemorrhage. The keratinaceous or colloid‑like
material released from cysts can induce an inflammatory
response, which could simulate primary tumor growth.
The biopsy from our patient showed no evidence of
reactive gliosis or foreign body reaction, however,
but was associated with some focal hemorrhage.
Alternatively, the accumulation of extracellular material
within cystic spaces can result in tumor expansion in the
absence of cellular proliferation.
Visualizing structural lesions using neuroradiological
imaging always involves a trade‑off between resolution
and signal‑to‑noise ratio. Although imaging technologies
are constantly improving the spatial resolution, the
possibility that a small tumor existed when this patient
was first studied cannot be excluded. In retrospect, the
initial study may not have been adequate to exclude
a small compressive lesion. Given the clinical setting
and knowledge of how rapidly a partially cystic
craniopharyngioma can enlarge, another MRI dedicated
to the chiasm with contrast should have been obtained.
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Because the signal intensity of tumors may blend with the
signal intensity of the suprasellar cistern on T2‑weighted
studies, small craniopharyngiomas large enough to
obliterate the suprasellar cistern can be missed.
It remains unclear at what interval neuro‑imaging should
be repeated when the clinical examination suggests a
compressive lesion but a recent study was unremarkable,
the potential difficulty of visualizing a small solid‑cystic
craniopharyngiomas in the suprasellar cistern must
be kept in mind. We recommend reviewing the recent
neuro‑imaging study to ensure the sellar‑chiasm was
adequately visualized. If not, then a repeat study
dedicated to this region, either MR with gadolinium or
CT scan with contrast, should be obtained. In the context
of unexplained bilateral vision loss, close monitoring for
a sellar mass is mandatory even when unremarkable
results are obtained on earlier scans.
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